Skip to content

Expectations and experiences of patients, experts and physicians with the term “immunotherapy” in cancer

Expectations and experiences of patients, experts and physicians with the term “immunotherapy” in cancer - SEEI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00011868
Enrollment
200
Registered
2017-03-22
Start date
2017-03-29
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

various cancers C00-C97

Interventions

Group 1: Interview and questionnaires with cancer patients undergoing immunotherapy regarding expectations and experiences with immunotherapy and chemotherapy. Group 2: Interview and questionnaires wi

Sponsors

Universitätsklinikum Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: General inclusion criteria for all members of the cohort: •Age = 18 Years •Native German speaker or fluent German speaker •Written declaration of consent For patients who received immunotherapy: •The patient is being treated with immunotherapy at the moment or was treated within the last year For patients who received chemotherapy: •The patient is being treated with chemotherapy at the moment or was treated within the last year •The patient has no personal experience with immunotherapy For patient who do not have cancer: •The patients never had cancer •Also their marriage partners, life partners and children never had cancer •They do not work in a medical profession For physicians: •The exercise of their profession is connected to direct patient contact as well as cancer therapies. In the past they had talks with patients about immunotherapy and chemotherapy. For staff members of cancer information services: •They had to deal with patient inquiries regarding immunotherapy, and give information about this topic

Exclusion criteria

Exclusion criteria: •Limited capacity to contract •Current cognitive reduction •Serious psychiatric diseases or the existence of a somatization disorder, a general anxiety disorder or a serious depression •Emotional stress •Pregnancy

Design outcomes

Primary

MeasureTime frame
Assessement of expectations and experiencies of patients, experts and physicians concerning cancer immunotherapy and chemotherapy with interviews and questionnaires

Secondary

MeasureTime frame
Comparison between immunotherapy and chemotherapy.

Countries

Germany

Contacts

Public ContactAndreas Ihrig

Sektion Psychoonkologie am Nationalen Centrum für Tumorerkrankungen

andreas.ihrig@med.uni-heidelberg.de06221564727

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 26, 2026